Logo image of 37C.DE

CNH INDUSTRIAL NV (37C.DE) Stock Fundamental Analysis

Europe - FRA:37C - NL0010545661 - Common Stock

9.25 EUR
-0.08 (-0.86%)
Last: 9/25/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, 37C scores 4 out of 10 in our fundamental rating. 37C was compared to 102 industry peers in the Machinery industry. 37C has an excellent profitability rating, but there are concerns on its financial health. 37C has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year 37C was profitable.
In the past year 37C had a positive cash flow from operations.
37C had positive earnings in 4 of the past 5 years.
37C had a positive operating cash flow in each of the past 5 years.
37C.DE Yearly Net Income VS EBIT VS OCF VS FCF37C.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

With a Return On Assets value of 1.88%, 37C perfoms like the industry average, outperforming 44.12% of the companies in the same industry.
The Return On Equity of 37C (10.67%) is better than 62.75% of its industry peers.
With a Return On Invested Capital value of 6.87%, 37C perfoms like the industry average, outperforming 59.80% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 37C is above the industry average of 9.17%.
The 3 year average ROIC (11.39%) for 37C is well above the current ROIC(6.87%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.88%
ROE 10.67%
ROIC 6.87%
ROA(3y)4.39%
ROA(5y)3.13%
ROE(3y)25.03%
ROE(5y)18.1%
ROIC(3y)11.39%
ROIC(5y)8.98%
37C.DE Yearly ROA, ROE, ROIC37C.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Profit Margin of 37C (4.55%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of 37C has grown nicely.
37C has a better Operating Margin (18.21%) than 90.20% of its industry peers.
37C's Operating Margin has improved in the last couple of years.
37C has a Gross Margin of 32.40%. This is in the lower half of the industry: 37C underperforms 63.73% of its industry peers.
37C's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.21%
PM (TTM) 4.55%
GM 32.4%
OM growth 3Y4.76%
OM growth 5Y12.67%
PM growth 3Y-10.76%
PM growth 5Y4.4%
GM growth 3Y5.77%
GM growth 5Y8.01%
37C.DE Yearly Profit, Operating, Gross Margins37C.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 37C is creating some value.
The number of shares outstanding for 37C has been reduced compared to 1 year ago.
The number of shares outstanding for 37C has been reduced compared to 5 years ago.
The debt/assets ratio for 37C is higher compared to a year ago.
37C.DE Yearly Shares Outstanding37C.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
37C.DE Yearly Total Debt VS Total Assets37C.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

37C has an Altman-Z score of 1.27. This is a bad value and indicates that 37C is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of 37C (1.27) is worse than 63.73% of its industry peers.
37C has a debt to FCF ratio of 12.84. This is a negative value and a sign of low solvency as 37C would need 12.84 years to pay back of all of its debts.
37C has a worse Debt to FCF ratio (12.84) than 65.69% of its industry peers.
37C has a Debt/Equity ratio of 3.55. This is a high value indicating a heavy dependency on external financing.
37C has a worse Debt to Equity ratio (3.55) than 92.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF 12.84
Altman-Z 1.27
ROIC/WACC0.88
WACC7.78%
37C.DE Yearly LT Debt VS Equity VS FCF37C.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 1.24 indicates that 37C should not have too much problems paying its short term obligations.
37C has a worse Current ratio (1.24) than 66.67% of its industry peers.
37C has a Quick Ratio of 1.24. This is a bad value and indicates that 37C is not financially healthy enough and could expect problems in meeting its short term obligations.
37C has a Quick ratio of 0.45. This is amonst the worse of the industry: 37C underperforms 90.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.45
37C.DE Yearly Current Assets VS Current Liabilites37C.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2

3. Growth

3.1 Past

The earnings per share for 37C have decreased strongly by -57.42% in the last year.
37C shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.29% yearly.
37C shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.73%.
Measured over the past years, 37C shows a decrease in Revenue. The Revenue has been decreasing by -6.71% on average per year.
EPS 1Y (TTM)-57.42%
EPS 3Y-6.6%
EPS 5Y5.29%
EPS Q2Q%-55.26%
Revenue 1Y (TTM)-21.73%
Revenue growth 3Y0.58%
Revenue growth 5Y-6.71%
Sales Q2Q%-14.16%

3.2 Future

Based on estimates for the next years, 37C will show a decrease in Earnings Per Share. The EPS will decrease by -3.32% on average per year.
37C is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.43% yearly.
EPS Next Y-43.42%
EPS Next 2Y-10.73%
EPS Next 3Y0.41%
EPS Next 5Y-3.32%
Revenue Next Year-11.23%
Revenue Next 2Y-4.22%
Revenue Next 3Y0.18%
Revenue Next 5Y0.43%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
37C.DE Yearly Revenue VS Estimates37C.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
37C.DE Yearly EPS VS Estimates37C.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.52 indicates a correct valuation of 37C.
66.67% of the companies in the same industry are more expensive than 37C, based on the Price/Earnings ratio.
37C's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.06.
The Price/Forward Earnings ratio is 12.40, which indicates a correct valuation of 37C.
Based on the Price/Forward Earnings ratio, 37C is valued a bit cheaper than 60.78% of the companies in the same industry.
37C is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.52
Fwd PE 12.4
37C.DE Price Earnings VS Forward Price Earnings37C.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 37C is on the same level as its industry peers.
37C's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 37C is cheaper than 85.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.37
EV/EBITDA 9.9
37C.DE Per share data37C.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of 37C may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.12
EPS Next 2Y-10.73%
EPS Next 3Y0.41%

4

5. Dividend

5.1 Amount

37C has a Yearly Dividend Yield of 2.25%.
37C's Dividend Yield is a higher than the industry average which is at 2.55.
Compared to an average S&P500 Dividend Yield of 2.38, 37C has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.25%

5.2 History

The dividend of 37C is nicely growing with an annual growth rate of 17.96%!
Dividend Growth(5Y)17.96%
Div Incr YearsN/A
Div Non Decr YearsN/A
37C.DE Yearly Dividends per share37C.DE Yearly Dividends per shareYearly Dividends per share 2022 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

40.58% of the earnings are spent on dividend by 37C. This is a bit on the high side, but may be sustainable.
DP40.58%
EPS Next 2Y-10.73%
EPS Next 3Y0.41%
37C.DE Yearly Income VS Free CF VS Dividend37C.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
37C.DE Dividend Payout.37C.DE Dividend Payout, showing the Payout Ratio.37C.DE Dividend Payout.PayoutRetained Earnings

CNH INDUSTRIAL NV

FRA:37C (9/25/2025, 7:00:00 PM)

9.25

-0.08 (-0.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners75.64%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap11.57B
Analysts74.78
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.25%
Yearly Dividend0.41
Dividend Growth(5Y)17.96%
DP40.58%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.67%
Min EPS beat(2)0.22%
Max EPS beat(2)19.11%
EPS beat(4)2
Avg EPS beat(4)-2.02%
Min EPS beat(4)-15.2%
Max EPS beat(4)19.11%
EPS beat(8)4
Avg EPS beat(8)1.32%
EPS beat(12)7
Avg EPS beat(12)4.43%
EPS beat(16)11
Avg EPS beat(16)9.24%
Revenue beat(2)2
Avg Revenue beat(2)9.97%
Min Revenue beat(2)8.01%
Max Revenue beat(2)11.93%
Revenue beat(4)4
Avg Revenue beat(4)6.86%
Min Revenue beat(4)0.52%
Max Revenue beat(4)11.93%
Revenue beat(8)8
Avg Revenue beat(8)5.17%
Revenue beat(12)12
Avg Revenue beat(12)5.89%
Revenue beat(16)14
Avg Revenue beat(16)3.4%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.52
Fwd PE 12.4
P/S 0.75
P/FCF 6.37
P/OCF 3.98
P/B 1.76
P/tB 4.77
EV/EBITDA 9.9
EPS(TTM)0.56
EY6.05%
EPS(NY)0.75
Fwd EY8.06%
FCF(TTM)1.45
FCFY15.7%
OCF(TTM)2.32
OCFY25.12%
SpS12.29
BVpS5.25
TBVpS1.94
PEG (NY)N/A
PEG (5Y)3.12
Profitability
Industry RankSector Rank
ROA 1.88%
ROE 10.67%
ROCE 8.87%
ROIC 6.87%
ROICexc 7.37%
ROICexgc 8.91%
OM 18.21%
PM (TTM) 4.55%
GM 32.4%
FCFM 11.82%
ROA(3y)4.39%
ROA(5y)3.13%
ROE(3y)25.03%
ROE(5y)18.1%
ROIC(3y)11.39%
ROIC(5y)8.98%
ROICexc(3y)13.27%
ROICexc(5y)10.68%
ROICexgc(3y)17.61%
ROICexgc(5y)15.03%
ROCE(3y)14.71%
ROCE(5y)11.59%
ROICexcg growth 3Y10.45%
ROICexcg growth 5Y8.32%
ROICexc growth 3Y26.67%
ROICexc growth 5Y7.09%
OM growth 3Y4.76%
OM growth 5Y12.67%
PM growth 3Y-10.76%
PM growth 5Y4.4%
GM growth 3Y5.77%
GM growth 5Y8.01%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF 12.84
Debt/EBITDA 7.02
Cap/Depr 209.48%
Cap/Sales 7.1%
Interest Coverage 250
Cash Conversion 87.57%
Profit Quality 259.42%
Current Ratio 1.24
Quick Ratio 0.45
Altman-Z 1.27
F-Score4
WACC7.78%
ROIC/WACC0.88
Cap/Depr(3y)198.21%
Cap/Depr(5y)185.92%
Cap/Sales(3y)5.02%
Cap/Sales(5y)7.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.42%
EPS 3Y-6.6%
EPS 5Y5.29%
EPS Q2Q%-55.26%
EPS Next Y-43.42%
EPS Next 2Y-10.73%
EPS Next 3Y0.41%
EPS Next 5Y-3.32%
Revenue 1Y (TTM)-21.73%
Revenue growth 3Y0.58%
Revenue growth 5Y-6.71%
Sales Q2Q%-14.16%
Revenue Next Year-11.23%
Revenue Next 2Y-4.22%
Revenue Next 3Y0.18%
Revenue Next 5Y0.43%
EBIT growth 1Y-28.56%
EBIT growth 3Y5.37%
EBIT growth 5Y5.11%
EBIT Next Year-16.49%
EBIT Next 3Y10.31%
EBIT Next 5YN/A
FCF growth 1Y1200.52%
FCF growth 3Y-27.46%
FCF growth 5YN/A
OCF growth 1Y290.51%
OCF growth 3Y-21.59%
OCF growth 5Y1.51%